The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics
Open accessAbstract
The RPE65 gene encodes the isomerase of the retinoid cycle, the enzymatic pathway that underlies mammalian vision. Mutations in RPE65 disrupt the retinoid cycle and cause a congenital human blindness known as Leber congenital amaurosis (LCA). We used adeno-associated virus-2-based RPE65 gene replacement therapy to treat three young adults with RPE65 -LCA and measured their vision before and up to 90 days after the intervention. All three patients showed a statistically significant increase in visual sensitivity at 30 days after treatment localized to retinal areas that had received the vector. There were no changes in the effect between 30 and 90 days. Both cone- and rod-photoreceptor-based vision could be demonstrated in treated areas. For cones, there were increases of up to 1.7 log units (i.e., 50 fold); and for rods, there were gains of up to 4.8 log units (i.e., 63,000 fold). To assess what fraction of full vision potential was restored by gene therapy, we related the degree of light sensitivity to the level of remaining photoreceptors within the treatment area. We found that the intervention could overcome nearly all of the loss of light sensitivity resulting from the biochemical blockade. However, this reconstituted retinoid cycle was not completely normal. Resensitization kinetics of the newly treated rods were remarkably slow and required 8 h or more for the attainment of full sensitivity, compared with <1 h in normal eyes. Cone-sensitivity recovery time was rapid. These results demonstrate dramatic, albeit imperfect, recovery of rod- and cone-photoreceptor-based vision after RPE65 gene therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K. A., Testa, F., Surace, E. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802315 · Cited by 2,145
Self-citationEffect of gene therapy on visual function in Leber’s congenital amaurosis
Bainbridge, J. W. B., Smith, A. J., Barker, S. S., Robbie, S., Henderson, R., Balaggan, K., Viswanathan, A., Holder, G. E., Stockman, A., Tyler, N., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802268 · Cited by 1,924
Gene therapy restores vision in a canine model of childhood blindness
Acland, G. M., Aguirre, G. D., Ray, J., Zhang, Q., Aleman, T. S., Cideciyan, A. V., Pearce-Kelling, S. E., Anand, V., Zeng, Y., Maguire, A. M., et al. (2001) · Nature Genetics · doi:10.1038/ng0501-92 · Cited by 1,202 · cited 13×
“We used adeno-associated virus-2-based RPE65 gene replacement therapy to treat three young adults with RPE65-LCA and measured their vision before and up to 90 days after the intervention.”
BackgroundInfluentialSelf-citationHauswirth, W. W., Aleman, T. S., Kaushal, S., Cideciyan, A. V., Schwartz, S. B., Wang, L., Conlon, T. J., Boye, S. L., Flotte, T. R., Byrne, B. J., et al. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.107 · Cited by 954
Self-citationRpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle
Redmond., T. M., Yu, S., Lee, E., Bok, D., Hamasaki, D., Chen, N., Goletz, P., Ma, J.-X., Crouch, R. K., & Pfeifer, K. (1998) · Nature Genetics · doi:10.1038/3813 · Cited by 929
RPE65 is the isomerohydrolase in the retinoid visual cycle
Moiseyev, G., Chen, Y., Takahashi, Y., Wu, B. X., & Ma, J.-X. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503460102 · Cited by 536
Acland, G. M., Aguirre, G. D., Bennett, J., Aleman, T. S., Cideciyan, A. V., Bennicelli, J., Dejneka, N. S., Pearce-Kelling, S. E., Maguire, A. M., Palczewski, K., et al. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.08.008 · Cited by 477
Self-citationEffective gene therapy with nonintegrating lentiviral vectors
Yáñez-Muñoz, R. J., Balaggan, K. S., MacNeil, A., Howe, S. J., Schmidt, M., Smith, A. J., Buch, P., MacLaren, R. E., Anderson, P. N., Barker, S. E., et al. (2006) · Nature Medicine · doi:10.1038/nm1365 · Cited by 460
Rpe65 is the retinoid isomerase in bovine retinal pigment epithelium
Jin, M., Li, S., Moghrabi, W. N., Sun, H., & Travis, G. H. (2005) · Cell · doi:10.1016/j.cell.2005.06.042 · Cited by 424
Diseases Caused by Defects in the Visual Cycle: Retinoids as Potential Therapeutic Agents
Travis, G. H., Golczak, M., Moise, A. R., & Palczewski, K. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105225 · Cited by 419
Redmond, T. M., Poliakov, E., Yu, S., Tsai, J.-Y., Lu, Z., & Gentleman, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504167102 · Cited by 409
Injury-induced upregulation of bFGF and CNTF mRNAS in the rat retina
Wen, R., Song, Y., Cheng, T., Matthes, M., Yasumura, D., LaVail, M., & Steinberg, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07377.1995 · Cited by 321
Phototransduction, Dark Adaptation, and Rhodopsin Regeneration The Proctor Lecture
Lamb, T. D., & Pugh, E. N. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.06-0849 · Cited by 313
Wenzel, A., Remé, C. E., Williams, T. P., Hafezi, F., & Grimm, C. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-01-00053.2001 · Cited by 290
Jacobson, S. G., Aleman, T. S., Cideciyan, A. V., Sumaroka, A., Schwartz, S. B., Windsor, E. A. M., Traboulsi, E. I., Heon, E., Pittler, S. J., Milam, A. H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500646102 · Cited by 274
Self-citationBennicelli, J., Wright, J. F., Komaromy, A., Jacobs, J. B., Hauck, B., Zelenaia, O., Mingozzi, F., Hui, D., Chung, D., Rex, T. S., et al. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300389 · Cited by 267
Cideciyan, A. V., Aleman, T. S., Swider, M., Schwartz, S. B., Steinberg, J. D., Brucker, A. J., Maguire, A. M., Bennett, J., Stone, E. M., & Jacobson, S. G. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh048 · Cited by 267
Self-citationFunctional and structural recovery of the retina after gene therapy in the RPE65 null mutation dog
Narfstro¨m, K., Katz, M. L., Bragadottir, R., Seeliger, M., Boulanger, A., Redmond, T. M., Caro, L., Lai, C.-M., & Rakoczy, P. E. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-0595 · Cited by 252
Saari, J. C., Nawrot, M., Kennedy, B. N., Garwin, G. G., Hurley, J. B., Huang, J., Possin, D. E., & Crabb, J. W. (2001) · Neuron · doi:10.1016/s0896-6273(01)00248-3 · Cited by 250
Seeliger, M. W., Grimm, C., Ståhlberg, F., Friedburg, C., Jaissle, G., Zrenner, E., Guo, H., Remé, C. E., Humphries, P., Hofmann, F., et al. (2001) · Nature Genetics · doi:10.1038/ng712 · Cited by 238
Jacobson, S. G., Acland, G. M., Aguirre, G. D., Aleman, T. S., Schwartz, S. B., Cideciyan, A. V., Zeiss, C. J., Komaromy, A. M., Kaushal, S., Roman, A. J., et al. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.03.005 · Cited by 224
Self-citationNight blindness in Sorsby's fundus dystrophy reversed by vitamin A
Jacobson, S. G., Cideciyan, A. V., Regunath, G., Rodriguez, F. J., Vandenburgh, K., Sheffield, V. C., & Stone, E. M. (1995) · Nature Genetics · doi:10.1038/ng0995-27 · Cited by 218
Self-citationLe Meur, G., Stieger, K., Smith, A. J., Weber, M., Deschamps, J. Y., Nivard, D., Mendes-Madeira, A., Provost, N., Péréon, Y., Cherel, Y., et al. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302861 · Cited by 207
Pang, J.-J., Chang, B., Kumar, A., Nusinowitz, S., Noorwez, S. M., Li, J., Rani, A., Foster, T. C., Chiodo, V. A., Doyle, T., et al. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.09.001 · Cited by 199
Self-citationIn Utero Gene Therapy Rescues Vision in a Murine Model of Congenital Blindness
Dejneka, N. S., Surace, E. M., Aleman, T. S., Cideciyan, A. V., Lyubarsky, A., Savchenko, A., Redmond, T. M., Tang, W., Wei, Z., Rex, T. S., et al. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2003.11.013 · Cited by 197
Self-citationHuman cone photoreceptor dependence on RPE65 isomerase
Jacobson, S. G., Alemán, T. S., Cideciyan, A. V., Héon, E., Golczak, M., Beltran, W. A., Sumaroka, A., Schwartz, S., Román, A. J., Windsor, E. A. M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706367104 · Cited by 164
Self-citationJacobson, S. G., Boye, S. L., Alemán, T. S., Conlon, T. J., Zeiss, C. J., Román, A. J., Cideciyan, A. V., Schwartz, S., Komáromy, A. M., Doobrajh, M., et al. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.845 · Cited by 157
Self-citationFGFR1, signaling, and AP-1 expression after retinal detachment: reactive Müller and RPE cells.
Geller, S. F., Lewis, G. P., & Fisher, S. K. (2001) · PubMed · Cited by 141
Bemelmans, A., Kostic, C., Crippa, S. V., Hauswirth, W. W., Lem, J., Munier, F. L., Seeliger, M. W., Wenzel, A., & Arsenijévic, Y. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030347 · Cited by 131
Self-citationAguirre, G. K., Komáromy, A. M., Cideciyan, A. V., Brainard, D. H., Alemán, T. S., Román, A. J., Avants, B., Gee, J. C., Korczykowski, M., Hauswirth, W. W., et al. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040230 · Cited by 121
Self-citationInterocular asymmetry of visual function in heterozygotes of X-linked retinitis pigmentosa
Jacobson, S. G., Yagasaki, K., Feuer, W. J., & Román, A. J. (1989) · Experimental Eye Research · doi:10.1016/0014-4835(89)90009-2 · Cited by 118
Self-citationCideciyan, A. V., Haeseleer, F., Fariss, R. N., Alemán, T. S., Jang, G.-F., Verlinde, C. L. M. J., Marmor, M. F., Jacobson, S. G., & Palczewski, K. (2000) · Visual Neuroscience · doi:10.1017/s0952523800175029 · Cited by 117
Self-citationIdentification of the RPE65 protein in mammalian cone photoreceptors.
Znoiko, S. L., Crouch, R. K., Moiseyev, G. P., & Xing, J. (2002) · PubMed · Cited by 107
Photoreceptor Layer Topography in Children with Leber Congenital Amaurosis Caused by RPE65 Mutations
Jacobson, S. G., Cideciyan, A. V., Alemán, T. S., Sumaroka, A., Windsor, E. A. M., Schwartz, S., Héon, E., & Stone, E. M. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2121 · Cited by 105
Self-citationSamardzija, M., Lintig, J. V., Tanimoto, N., Oberhauser, V., Thiersch, M., Remé, C. E., Seeliger, M. W., Grimm, C., & Wenzel, A. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm304 · Cited by 102
Zhang, H., Fan, J., Li, S., Karan, S., Rohrer, B., Palczewski, K., Frederick, J. M., Crouch, R. K., & Baehr, W. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0317-08.2008 · Cited by 101
Alemán, T. S., Jacobson, S. G., Chico, J. D., Scott, M. L., Cheung, A. Y., Windsor, E. A. M., Furushima, M., Redmond, T. M., Bennett, J., Palczewski, K., et al. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-1230 · Cited by 101
Self-citationLai, C., Yu, M. J. T., Brankov, M., Barnett, N. L., Zhou, X., Redmond, T. M., Narfström, K. L., & Rakoczy, P. E. (2004) · Genetic Vaccines and Therapy · doi:10.1186/1479-0556-2-3 · Cited by 97
Jacobson, S. G., Cideciyan, A. V., Alemán, T. S., Sumaroka, A., Schwartz, S., Windsor, E. A. M., Román, A. J., Héon, E., Stone, E. M., & Thompson, D. A. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0599 · Cited by 84
Self-citationRPE65 Gene Delivery Restores Isomerohydrolase Activity and Prevents Early Cone Loss in Rpe65−/−Mice
Chen, Y., Moiseyev, G., Takahashi, Y., & Ma, J.-X. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0965 · Cited by 80
Phenotypic marker for early disease detection in dominant late-onset retinal degeneration.
Jacobson, S. G., Cideciyan, A. V., Wright, E., & Wright, A. F. (2001) · PubMed · Cited by 73
Self-citationCorrelation of Regenerable Opsin with Rod ERG Signal in Rpe65 −/− Mice during Development and Aging
Rohrer, B., Goletz, P. W., Znoiko, S., Ablonczy, Z., Ma, J., Redmond, T. M., & Crouch, R. K. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-0567 · Cited by 64
Lyubarsky, A., Savchenko, A. B., Morocco, S. B., Daniele, L. L., Redmond, T. M., & Pugh, E. N. (2005) · Biochemistry · doi:10.1021/bi0505363 · Cited by 63
Rod plateaux during dark adaptation in Sorsby's fundus dystrophy and vitamin A deficiency.
Cideciyan, A. V., Pugh, E. N., Lamb, T. D., Huang, Y., & Jacobson, S. G. (1997) · PubMed · Cited by 61
Self-citationEvidence for RPE65‐independent vision in the cone‐dominated zebrafish retina
Schönthaler, H. B., Lampert, J. M., Isken, A., Rinner, O., Mader, A., Gesemann, M., Oberhauser, V., Golczak, M., Biehlmaier, O., Palczewski, K., et al. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05801.x · Cited by 57
Collery, R., McLoughlin, S., Vendrell, V., Finnegan, J., Crabb, J. W., Saari, J. C., & Kennedy, B. N. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-1957 · Cited by 56
Prenatal human ocular degeneration occurs in Leber's congenital amaurosis (LCA2)
Porto, F. B. O., Perrault, I., Hicks, D., Rozet, J., Hanoteau, N., Hanein, S., Kaplan, J., & Sahel, J. (2002) · The Journal of Gene Medicine · doi:10.1002/jgm.278 · Cited by 53
Nrl -Knockout Mice Deficient in Rpe65 Fail to Synthesize 11- cis Retinal and Cone Outer Segments
Feathers, K. L., Lyubarsky, A., Khan, N. W., Teofilo, K., Swaroop, A., Williams, D. S., Pugh, E. N., & Thompson, D. A. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-1234 · Cited by 47
Hauswirth, W. W., Alemán, T. S., Kaushal, S., Cideciyan, A. V., Schwartz, S., Wang, L., Conlon, T. J., Boye, S. L., Flotte, T. R., Byrne, B. J., et al. (2008) · Human Gene Therapy · doi:10.1089/hgt.2008.107 · Cited by 47
Self-citationIntroducing Trevor D. Lamb and Edward N. Pugh, Jr, the 2006 Recipients of the Proctor Medal
Yau, K. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0187 · Cited by 43
Takahashi, Y., Chen, Y., Moiseyev, G. P., & Ma, J.-X. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603725200 · Cited by 42
Rod/cone rivalry in pigment regeneration
Rushton, W. A. H. (1968) · The Journal of Physiology · doi:10.1113/jphysiol.1968.sp008603 · Cited by 40
Román, A. J., Sl, B., Alemán, T. S., Jj, P., McDowell, J. H., Se, B., Cideciyan, A. V., Jacobson, S. G., & Hauswirth, W. (2007) · PubMed · Cited by 36
Self-citationRPE65 surface epitopes, protein interactions, and expression in rod- and cone-dominant species.
Hemati, N., Feathers, K. L., Chrispell, J. D., Reed, D. M., Carlson, T. J., & Thompson, D. A. (2005) · PubMed · Cited by 34
Poehner, W., Fossarello, M., Rapoport, A., Alemán, T. S., Cideciyan, A. V., Jacobson, S. G., Wright, A. F., Danciger, M., & Farber, D. B. (2000) · PubMed · Cited by 26
Self-citationPriore, L. V. D. (2005) · Archives of Ophthalmology · doi:10.1001/archopht.123.8.1156-a · Cited by 8
Cited by
Adeno-associated virus vector as a platform for gene therapy delivery
Wang, D., Tai, P. W. L., & Gao, G. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0012-9 · Cited by 2,444
Gene therapy clinical trials worldwide to 2012 – an update
Ginn, S. L., Alexander, I. E., Edelstein, M. L., Abedi, M. R., & Wixon, J. (2013) · The Journal of Gene Medicine · doi:10.1002/jgm.2698 · Cited by 1,159
Effect of genome size on AAV vector packaging
Wu, Z., Yang, H., & Colosi, P. (2010) · Molecular Therapy · doi:10.1038/mt.2009.255 · Cited by 1,029
Immune responses to AAV vectors: overcoming barriers to successful gene therapy
Mingozzi, F., & High, K. A. (2013) · Blood · doi:10.1182/blood-2013-01-306647 · Cited by 955
Maguire, A. M., High, K. A., Auricchio, A., Wright, J. F., Pierce, E. A., Testa, F., Mingozzi, F., Bennicelli, J. L., Ying, G.-S., Rossi, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61836-5 · Cited by 865
Self-citation
Metadata
- Authors
- Cideciyan, A. V., Aleman, T. S., Boye, S. L., Schwartz, S. B., Kaushal, S., Roman, A. J., Pang, J.-J., Sumaroka, A., Windsor, E. A. M., Wilson, J. M., Flotte, T. R., Fishman, G. A., Heon, E., Stone, E. M., Byrne, B. J., Jacobson, S. G., & Hauswirth, W. W.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2008-09-30
- Volume
- 105
- Issue
- 39
- Pages
- 15112-15117
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2022040013
- Cited by
- 673
- References
- 56
- FWCI
- 22.33
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.